Connacht Asset Management LP Bausch Health Companies Inc. Transaction History

Connacht Asset Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $51,451 - $66,195	-2,382 Reduced 3.88%	59,043 $1.35 Million
Q4 2021 Feb 11, 2022	BUY	$23.0 - $29.01 $287,293 - $362,363	12,491 Added 25.53%	61,425 $1.7 Million
Q3 2021 Nov 15, 2021	SELL	$25.04 - $30.06 $870,766 - $1.05 Million	-34,775 Reduced 41.54%	48,934 $1.36 Million
Q2 2021 Aug 16, 2021	BUY	$27.43 - $32.7 $10,313 - $12,295	376 Added 0.45%	83,709 $2.45 Million
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $216,200 - $347,822	-10,117 Reduced 10.83%	83,333 $2.65 Million
Q4 2020 Feb 12, 2021	BUY	$15.31 - $21.12 $1.43 Million - $1.97 Million	93,450 New	93,450 $1.94 Million

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Connacht Asset Management LP with notifications on news.